These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1377980)

  • 1. Canadian MDs begin major push to promote early detection of prostate cancer.
    Spurgeon D
    CMAJ; 1992 Jul; 147(2):220-2. PubMed ID: 1377980
    [No Abstract]   [Full Text] [Related]  

  • 2. Early detection of prostate cancer. Recommendations from the Canadian Urological Association.
    Ramsey EW
    Can J Oncol; 1994 Nov; 4 Suppl 1():82-5. PubMed ID: 8853498
    [No Abstract]   [Full Text] [Related]  

  • 3. Study shows PSA better than DRE in screening for prostate cancer.
    Oncology (Williston Park); 1991 Nov; 5(11):36. PubMed ID: 1722420
    [No Abstract]   [Full Text] [Related]  

  • 4. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 5. Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1991 Sep; 145(5):413-28. PubMed ID: 1878824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consensus conference. The detection of localized cancer of the prostate. Paris, 8-9 December 1989].
    Ann Urol (Paris); 1990; 24(1):5-8. PubMed ID: 1690964
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
    Kabalin JN
    Geriatrics; 1992 Sep; 47(9):26-32. PubMed ID: 1380941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality. A case-control study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1824-5. PubMed ID: 16217296
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer: the epidemiologic perspective.
    Levy I
    Can J Oncol; 1994 Nov; 4 Suppl 1():4-7. PubMed ID: 8853479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of cancer of the prostate. A study of 600 cases].
    Teillac P; Bron J; Tobolski F; Cussenot O; Lesourd A; Leroy M; Toubert ME; Brocheriou C; Laval-Jeantet M; Le Duc A
    Ann Urol (Paris); 1990; 24(1):37-41. PubMed ID: 1690963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underutilization of digital rectal examination when screening for prostate cancer.
    Murthy GD; Byron DP; Pasquale D
    Arch Intern Med; 2004 Feb; 164(3):313-6. PubMed ID: 14769627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consultation corner. Prostate screening: refining what PSA levels mean.
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2007 Oct; 19(8):6. PubMed ID: 18229418
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory studies for the detection of carcinoma of the prostate.
    Brawer MK
    Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the prostate-specific antigen useful in the detection of prostatic cancer?].
    Morote Robles J; Ruibal Morell A
    Med Clin (Barc); 1987 Nov; 89(15):663. PubMed ID: 2448558
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for prostate cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949
    [No Abstract]   [Full Text] [Related]  

  • 17. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
    de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
    Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP; Sokolov AV; Bukharkin BV; Ledian KM; Tilk AE; Makarova GV
    Urol Nefrol (Mosk); 1991; (4):8-12. PubMed ID: 1719686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
    Zhao XJ; Kong XB; Wang WH
    Zhonghua Nan Ke Xue; 2003 Nov; 9(8):563-5, 568. PubMed ID: 14689882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.